Skip to main content
AI test might improve stratification of pancreatic cysts

An artificial intelligence-driven algorithm developed by Johns Hopkins researchers dubbed CompCyst could improve the diagnosis of pancreatic cysts and help differentiate patients at risk for cancer who need surgery from those with a low cancer risk who may be candidates for monitoring. The algorithm, described in Science Translational Medicine, is meant to complement imaging and genetic tests, says research fellow Marco Dal Molin.

Full Story: